Drugs / CC49-deltaCH2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00023933 | Oct 2001 → Jul 2005 | colon adenocarcinoma, rectum adenocarcinoma | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CC49-deltaCH2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00023933 ↗ |
| Modality | Monoclonal antibody | “Treatment (monoclonal antibody)” NCT00023933 ↗ |
| Route | Intravenous | “Given IV” NCT00023933 ↗ |